Can you buy Unlearn stock?

As Unlearn is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company likeUnlearn, you must be an accredited investor . If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Unlearn stock?

To invest in a private company like Unlearn through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process . 1. Create a free account to access Forge’s marketplace. 2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies. 3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Unlearn stock?

Yes, you may be able to sell your Unlearn stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Unlearn stock?

If you hold private company shares of Unlearn - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Unlearn stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Is Unlearn a public company?

No, Unlearn is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Unlearn’s stock price?

Unlearn is a privately held company and therefore does not have a public stock price. However, you may access Unlearn’s private market stock price with Forge Data .

What is Unlearn’s stock ticker symbol?

Unlearn does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Invest and Sell Unlearn Stock

Businesswire 02/16/2024

Unlearn Raises $50 Million Series C to Optimize Clinical Research With AI-Powered Digital Twin Technology

Unlearn, an AI company creating digital twins of clinical trial participants that enable smaller, faster studies, today announced a $50M Series C round led by Altimeter Capital, joined by returning investors Radical Ventures, Wittington Ventures, Mubadala Capital, Epic Ventures, and Necessary Venture Capital.

Fierce Biotech 02/09/2024

Digital twin developer Unlearn sees double with 2nd $50M venture capital round

Unlearn seems to have retained a lesson or two about fundraising: The digital twin developer announced this week that it has raised another $50 million, echoing its last funding round two years ago. The series C was led by Altimeter Capital, with additional support from many of the backers that had previously joined in on Unlearn’s early 2022 series B round, including that round’s leader, Insight Partners, as well as 8VC, DCVC and DCVC Bio, among others.

Reuters 03/21/2023

Biotech AI startup Unlearn adds $15 mln and OpenAI CTO to board

Unlearn.AI, which has built a machine learning platform that creates "digital twin" profiles of patients in clinical trials, has raised $15 million to expand partnerships and accelerate regulatory approval, the company told Reuters on Tuesday.

The Wall Street Journal 01/01/2023

A Perk to Getting These Jobs: You Pick Your Pay

Unlearn, which uses artificial intelligence to speed clinical trials, recently began offering new hires multiple pay options. It’s among a growing number of companies that let new hires customize their compensation with different combinations of salary, equity and, in some cases, benefits.

Unlearn Stock

Register To Buy and Sell Shares

Enterprise Value

Access Unlearn’s valuation and stock price.

Unlearn investors also invested in these private companies

Team

Management Team

Board Members

Unlearn stock FAQs